A simple fluorescence based assay for quantification of human immunodeficiency virus particle release

BMC Biotechnology

Volumn 10, Issue , 2010, Pages

  Hermle, Johannes ^a   Anders, Maria ^a   Heuser, Anke Mareil ^a   Müller, Barbara ^a  

^a UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

96-WELL FORMAT; ANTIRETROVIRALS; CELL LYSATES; CELL-BASED ASSAYS; EXPRESSION EFFICIENCY; FLUORESCENCE ANALYSIS; FLUORESCENCE INTENSITIES; HIGH THROUGHPUT SCREENING; HOST CELL FACTORS; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS TYPE-1; INFECTED CELLS; LATE STAGE; PARTICLE ASSEMBLIES; PARTICLE FORMATIONS; PARTICLE RELEASE; POTENTIAL INHIBITORS; RANDOM SCREENING; ROBUST DETECTION; SIMPLE METHOD; SPECIFIC INHIBITORS; STANDARD METHOD; STRUCTURAL PROTEINS; VIRAL PROTEINS; VIRUS-LIKE PARTICLES;

CELL CULTURE; CHEMICAL COMPOUNDS; DRUG PRODUCTS; FLUORESCENCE; FLUORESCENCE SPECTROSCOPY; LEAD COMPOUNDS; LIBRARIES; PROTEINS; RNA; TISSUE CULTURE;

VIRUSES;

ANTIGEN P24; ENHANCED YELLOW FLUORESCENT PROTEIN; FLUORESCENT DYE; GAG PROTEIN; SMALL INTERFERING RNA; UNCLASSIFIED DRUG;

ARTICLE; CELL ASSAY; CELL LYSATE; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE ANALYSIS; FLUORESCENCE SPECTROSCOPY; HOST CELL; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; METHODOLOGY; NONHUMAN; PROTEIN DOMAIN; PROTEIN EXPRESSION; SCREENING TEST; SUPERNATANT; TISSUE CULTURE; VALIDATION PROCESS; VIRUS ASSEMBLY; VIRUS CAPSID; VIRUS PARTICLE; VIRUS RELEASE; VIRUS REPLICATION; CELL LINE; FLUORESCENCE; ISOLATION AND PURIFICATION; PHYSIOLOGY;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; MIRIDAE;

CELL LINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; FLUORESCENCE; GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS; HIV-1; HUMANS; RNA, SMALL INTERFERING; VIRUS ASSEMBLY; VIRUS RELEASE;

EID: 77950927781     PISSN: None     EISSN: 14726750     Source Type: Journal    
DOI: 10.1186/1472-6750-10-32     Document Type: Article

References (33)

1. Hofmann WP, Soriano V, Zeuzem S. Antiviral combination therapy for treatment of chronic hepatitis B, hepatitis C, and human immunodeficiency virus infection. Handbook of experimental pharmacology 2009, (189):321-346. full_text, 19048206.
2. Li F, Goila-Gaur R, Salzwedel K, Kilgore NR, Reddick M, Matallana C, Castillo A, Zoumplis D, Martin DE, Orenstein JM, Allaway GP, Freed EO, Wild CT. PA-457: a potent HIV inhibitor that disrupts core condensation by targeting a late step in Gag processing. Proceedings of the National Academy of Sciences of the United States of Americ 2003, 100(23):13555-13560.
3. Salzwedel K, Martin DE, Sakalian M. Maturation inhibitors: a new therapeutic class targets the virus structure. AIDS reviews 2007, 9(3):162-172.
4. Tang C, Loeliger E, Kinde I, Kyere S, Mayo K, Barklis E, Sun Y, Huang M, Summers MF. Antiviral inhibition of the HIV-1 capsid protein. Journal of molecular biology 2003, 327(5):1013-1020. 10.1016/S0022-2836(03)00289-4, 12662926.
5. Kelly BN, Kyere S, Kinde I, Tang C, Howard BR, Robinson H, Sundquist WI, Summers MF, Hill CP. Structure of the antiviral assembly inhibitor CAP-1 complex with the HIV-1 CA protein. Journal of molecular biology 2007, 373(2):355-366. 10.1016/j.jmb.2007.07.070, 2066180, 17826792.
6. Sticht J, Humbert M, Findlow S, Bodem J, Müller B, Dietrich U, Werner J, Kräusslich HG. A peptide inhibitor of HIV-1 assembly in vitro. Nature structural & molecular biology 2005, 12(8):671-677.
7. Ternois F, Sticht J, Duquerroy S, Kräusslich HG, Rey FA. The HIV-1 capsid protein C-terminal domain in complex with a virus assembly inhibitor. Nature structural & molecular biology 2005, 12(8):678-682.
8. Zhang H, Zhao Q, Bhattacharya S, Waheed AA, Tong X, Hong A, Heck S, Curreli F, Goger M, Cowburn D, Freed EO, Debnath AK. A cell-penetrating helical peptide as a potential HIV-1 inhibitor. Journal of molecular biology 2008, 378(3):565-580. 10.1016/j.jmb.2008.02.066, 2695608, 18374356.
9. Wollert T, Yang D, Ren X, Lee HH, Im YJ, Hurley JH. The ESCRT machinery at a glance. Journal of Cell Science 2009, 122(Pt 13):2163-6. 10.1242/jcs.029884, 19535731.
10. Morita E, Sundquist WI. Retrovirus budding. Annual review of cell and developmental biology 2004, 20:395-425. 10.1146/annurev.cellbio.20.010403.102350, 15473846.
11. Klein KC, Reed JC, Lingappa JR. Intracellular destinies: degradation, targeting, assembly, and endocytosis of HIV Gag. AIDS Reviews 2007, 9(3):150-61.
12. Bieniasz PD. The cell biology of HIV-1 virion genesis. Cell host & microbe 2009, 5(6):550-8.
13. Brass AL, Dykxhoorn DM, Benita Y, Yan N, Engelman A, Xavier RJ, Lieberman J, Elledge SJ. Identification of host proteins required for HIV infection through a functional genomic screen. Science 2008, 319(5865):921-926. 10.1126/science.1152725, 18187620.
14. König R, Zhou Y, Elleder D, Diamond TL, Bonamy GM, Irelan JT, Chiang CY, Tu BP, De Jesus PD, Lilley CE, Seidel S, Opaluch AM, Caldwell JS, Weitzman MD, Kuhen KL, Bandyopadhyay S, Ideker T, Orth AP, Miraglia LJ, Bushman FD, Young JA, Chanda SK. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 2008, 135(1):49-60. 10.1016/j.cell.2008.07.032, 2628946, 18854154.
15. Zhou H, Xu M, Huang Q, Gates AT, Zhang XD, Castle JC, Stec E, Ferrer M, Strulovici B, Hazuda DJ, Espeseth AS. Genome-scale RNAi screen for host factors required for HIV replication. Cell host & microbe 2008, 4(5).
16. Goff SP. Knockdown screens to knockout HIV-1. Cell 2008, 135(3):417-420. 10.1016/j.cell.2008.10.007, 18984154.
17. Bushman FD, Malani N, Fernandes J, D'Orso I, Cagney G, Diamond TL, Zhou H, Hazuda DJ, Espeseth AS, Konig R, Bandyopadhyay S, Ideker T, Goff SP, Krogan NJ, Frankel AD, Young JA, Chanda SK. Host cell factors in HIV replication: meta-analysis of genome-wide studies. PLoS pathogens 2009, 5(5):e1000437. 10.1371/journal.ppat.1000437, 2682202, 19478882.
18. Prudencio M, Lehmann MJ. Illuminating the host - how RNAi screens shed light on host-pathogen interactions. Biotechnology journal 2009, 4(6):826-837. 10.1002/biot.200900071, 19507150.
19. Müller B, Daecke J, Fackler OT, Dittmar MT, Zentgraf H, Kräusslich HG. Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative. Journal of virology 2004, 78(19):10803-10813. 10.1128/JVI.78.19.10803-10813.2004, 516407, 15367647.
20. Lampe M, Briggs JA, Endress T, Glass B, Riegelsberger S, Kräusslich HG, Lamb DC, Bräuchle C, Müller B. Double-labelled HIV-1 particles for study of virus-cell interaction. Virology 2007, 360(1):92-104. 10.1016/j.virol.2006.10.005, 17097708.
21. Ivanchenko S, Godinez WJ, Lampe M, Kräusslich HG, Eils R, Rohr K, Bräuchle C, Müller B, Lamb DC. Dynamics of HIV-1 Assembly and Release. PLoS Pathogens 2009, 5(11):e1000652. 10.1371/journal.ppat.1000652, 2766258, 19893629.
22. Campbell RE, Tour O, Palmer AE, Steinbach PA, Baird GS, Zacharias DA, Tsien RY. A monomeric red fluorescent protein. Proceedings of the National Academy of Sciences of the United States of America 2002, 99(12):7877-7882. 10.1073/pnas.082243699, 122988, 12060735.
23. Huang M, Orenstein JM, Martin MA, Freed EO. p6Gag is required for particle production from full-length human immunodeficiency virus type 1 molecular clones expressing protease. Journal of virology 1995, 69(11):6810-6818. 189593, 7474093.
24. Carlson LA, Briggs JA, Glass B, Riches JD, Simon MN, Johnson MC, Müller B, Grunewald K, Kräusslich HG. Three-dimensional analysis of budding sites and released virus suggests a revised model for HIV-1 morphogenesis. Cell host & microbe 2008, 4(6):592-599.
25. Ly TD, Ebel A, Faucher V, Fihman V, Laperche S. Could the new HIV combined p24 antigen and antibody assays replace p24 antigen specific assays?. Journal of virological methods 2007, 143(1):86-94. 10.1016/j.jviromet.2007.02.013, 17395277.
26. Ono A, Waheed AA, Joshi A, Freed EO. Association of human immunodeficiency virus type 1 gag with membrane does not require highly basic sequences in the nucleocapsid: use of a novel Gag multimerization assay. Journal of virology 2005, 79(22):14131-14140. 10.1128/JVI.79.22.14131-14140.2005, 1280195, 16254348.
27. Wyma DJ, Jiang J, Shi J, Zhou J, Lineberger JE, Miller MD, Aiken C. Coupling of human immunodeficiency virus type 1 fusion to virion maturation: a novel role of the gp41 cytoplasmic tail. Jornal of virology 2004, 78(7):3429-35.
28. Zhang JH, Chung TD, Oldenburg KR. A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. Journal of Biomolecular Screening 1999, 4(2):67-73. 10.1177/108705719900400206, 10838414.
29. Erfle H, Neumann B, Liebel U, Rogers P, Held M, Walter T, Ellenberg J, Pepperkok R. Reverse transfection on cell arrays for high content screening microscopy. Nature protocols 2007, 2(2):392-399. 10.1038/nprot.2006.483, 17406600.
30. Erfle H, Neumann B, Rogers P, Bulkescher J, Ellenberg J, Pepperkok R. Work flow for multiplexing siRNA assays by solid-phase reverse transfection in multiwell plates. J Biomol Screen 2008, 13(7):575-580. 10.1177/1087057108320133, 18599879.
31. Garrus JE, von Schwedler UK, Pornillos OW, Morham SG, Zavitz KH, Wang HE, Wettstein DA, Stray KM, Côté M, Rich RL, Myszka DG, Sundquist WI. Tsg101 and the vacuolar protein sorting pathway are essential for HIV-1 budding. Cell 2001, 107(1):55-65. 10.1016/S0092-8674(01)00506-2, 11595185.
32. Konvalinka J, Litterst MA, Welker R, Kottler H, Rippmann F, Heuser AM, Kräusslich HG. An active-site mutation in the human immunodeficiency virus type 1 proteinase (PR) causes reduced PR activity and loss of PR-mediated cytotoxicity without apparent effect on virus maturation and infectivity. Journal of virology 1995, 69(11):7180-7186. 189639, 7474139.
33. Börner K, Hermle J, Sommer C, Brown NP, Knapp B, Glass B, Kunkel J, Torralba G, Reymann J, Beil N, Beneke J, Pepperkok R, Schneider R, Ludwig T, Hausmann M, Hamprecht F, Erfle H, Kaderali L, Kräusslich HG, Lehmann MJ. From experimental setup to bioinformatics: an RNAi screening platform to identify host factors involved in HIV-1 replication. Biotechnology journal 2010, 5(1):39-49. 10.1002/biot.200900226, 20013946.